CJC-1295 + Ipamorelin
This is a two-in-one growth-hormone blend that works with your body instead of overriding it.
No trial has studied this one. Everything below comes from community-reported dosing and results — what people actually run, and what they report happening.
- Longevity & anti-aging
- Recovery & injury
- Skin & hair
- Sleep
The quick answer
This is a two-in-one growth-hormone blend that works with your body instead of overriding it. CJC-1295 tells your pituitary to release growth hormone; Ipamorelin triggers a clean pulse through a second pathway and eases off the body's "off switch." Together they raise your own GH in a natural, pulsing rhythm - without the cortisol or hunger spikes of older compounds.
It's a slow build. Most people notice deeper, more vivid sleep in the first week or two, better recovery and skin over the next few weeks, and the body-composition changes they're really after around the two-to-three-month mark. The bedtime dose matters most, since it rides your natural overnight GH pulse.
What it is not
No study has ever looked at this combination. The grade reflects the blend, not its components.
Why people use it
😴 Deep, restorative sleep; 💪 Faster recovery and lean muscle; 📉 Gradual fat loss; ✨ Better skin, hair and nails; 🕒 Raises your own growth hormone naturally
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
- How often
- Every night, 2+ hrs after eating
- Route
- subcutaneous
- Evidence for this
- Small human studies
Deeper sleep first - usually within the first week or two - then recovery and body composition over the following months.
- How often
- Every night, 2+ hrs after eating
- Route
- subcutaneous
- Evidence for this
- Small human studies
Deeper sleep first - usually within the first week or two - then recovery and body composition over the following months.
- How often
- Every night, 2+ hrs after eating
- Route
- subcutaneous
- Evidence for this
- Small human studies
Deeper sleep first - usually within the first week or two - then recovery and body composition over the following months.
- How often
- Every night, 30-60 min before lights out
- Route
- subcutaneous
- Evidence for this
- Small human studies
Deeper sleep in the first half of the night, often inside the first week or two.
10mg blend vial + 3ml BAC water = 3.33mg/ml. 0.3mg = 9u, 0.4mg = 12u, 0.5mg = 15u. Nightly at bedtime, 2+ hrs after eating.
Work out your own units on the reconstitution calculator — the most common serious mistake in this area is arithmetic, not chemistry.
What to expect, and when
- First thing people notice
- Weeks 1–2 (sleep quality)
- When it gets real
- Weeks 2–4 (recovery, energy)
- Where it peaks
- Months 2–3 (body comp, skin)
- Patience needed
- High - 2–3 months
- Weeks 1–2Deeper sleep, easier mornings
Growth hormone is released most strongly during deep sleep, and the earliest change users commonly report on GHRH-analog protocols is improved sleep depth and quality. In healthy adults, CJC-1295 has been shown to raise GH and IGF-1 levels, while ipamorelin is a selective secretagogue that adds a GH pulse without meaningfully raising cortisol or prolactin. Effects at this stage are subtle and largely subjective.
- Weeks 2–4Recovery and steadier daytime energy
As sleep consolidates, users frequently describe faster recovery between training sessions and more consistent energy. Research on CJC-1295 shows a single injection can raise mean GH 2- to 10-fold and IGF-1 1.5- to 3-fold for several days, and IGF-1 is the mediator most associated with tissue repair. These recovery reports are largely anecdotal rather than trial-confirmed endpoints.
- Weeks 4–8Leaner feel, training output
Around the one- to two-month mark, users often note a leaner appearance and better workout capacity, effects plausibly linked to sustained IGF-1 elevation. Preclinical and mechanistic evidence connects the GH/IGF-1 axis to lean-mass support and fat metabolism. However, most controlled study of these peptides has measured hormone levels rather than long-term body-composition outcomes.
- Months 2–3Body composition and skin quality
The changes most people are patient for - shifts in body composition and skin texture - tend to accumulate over two to three months, consistent with how slowly collagen and lean tissue remodel. Research suggests the hormonal signal is well documented, while these downstream cosmetic and body-composition endpoints rest more on user reports than on rigorous trials. Benefits generally regress after the protocol ends.
These peptides are not FDA-approved; the GH/IGF-1 rise is well documented but long-term body-composition and anti-aging outcomes rest largely on user reports, and regulators have flagged immunogenicity and cardiovascular concerns.
Side effects, and what people do about them
Most people do great on this. As your growth hormone gently rises you might notice a bit of water retention, slightly tingly hands, or more vivid dreams in the first week or two - usually mild and often settling as your body adjusts or with a small dose tweak. If you're diabetic or keeping an eye on blood sugar, just loop in your doctor so you can monitor it comfortably.
Go deeper
Open these only if you want them.
How it actually works
Two compounds hitting two different receptors that converge on the same output. CJC-1295 is a growth-hormone-releasing-hormone analogue and binds the GHRH receptor on pituitary somatotrophs. Ipamorelin is a selective agonist at GHS-R1a, the ghrelin receptor, and additionally eases off somatostatin, the body's own brake on growth-hormone release.
Because the two arrive by separate routes, the pulse is larger than either produces alone, and because ipamorelin is selective it does this without the cortisol, prolactin and hunger that older, less selective secretagogues brought with them.
For stacking, the practical consequence is specific and frequently got wrong: tesamorelin is also a GHRH analogue, so adding it to this is doubling the GHRH half and leaving the other half untouched. The non-redundant component here is the ipamorelin.
What people report, in full
Sleep is what people notice first, usually around two to three weeks, and vivid dreams come up so consistently that people use them as their informal sign the vial is real. Recovery and body-composition changes are described later, around four to eight weeks, and they are described as modest rather than dramatic. The warm flush in the face is the most talked-about effect, and the community's own view on it is worth repeating: it is a histamine response, not a sign of potency. Some people find it settles if they inject about half an hour before bed. Two things are worth knowing before you compare notes with anyone. CJC-1295 is sold in two forms - with DAC it lasts the best part of a week, without DAC it is gone in half an hour - and people routinely discuss them as if they were the same thing. And pairing it with Tesamorelin is common and mostly done to make Tesamorelin affordable; the sensible half of that pairing is the Ipamorelin, which works through a different receptor. Tesamorelin plus CJC-1295 is two of the same kind of thing.
Sources and review
Everything above was written from the research and community reporting behind this compound, but we have not yet attached the citations. We would rather tell you that than let the page imply sources it does not have. This is being backfilled.
Last reviewed 2026-09-06.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about CJC-1295 + Ipamorelin